Investigation Overview
April 4, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Carbylan Therapeutics Inc (NASDAQ:CBYL) shares over potential securities laws violations by Carbylan Therapeutics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of t...
You must register (for free) or login to view the entire investigation.